Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott Laboratories | Santiago | Salute | Attrezzature e forniture medicali | 212,78 Bln CLP | 17x | 0,12 | 108.200 CLP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pfizer | Santiago | Salute | Prodotti farmaceutici | 136,63 Bln CLP | 18x | 0,06 | 25.102,55 CLP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CVS Health | Santiago | Salute | Fornitori e servizi sanitari | 78,38 Bln CLP | 18,1x | -0,33 | 49.954,66 CLP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CVS Health | Santiago | Salute | Fornitori e servizi sanitari | 77,96 Bln CLP | 18,1x | -0,33 | 62.268 CLP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biogen | Santiago | Salute | Prodotti farmaceutici | 18,98 Bln CLP | 12,4x | 1,27 | 235.998,70 CLP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Inst Diagnosti | Santiago | Salute | Fornitori e servizi sanitari | 278,34 Mrd CLP | 39,3x | 0,08 | 1.975 CLP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Las Condes | Santiago | Salute | Fornitori e servizi sanitari | 116,8 Mrd CLP | -13,3x | -4,54 | 13.945 CLP | 3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |